FERRARI, Stefania
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.197
EU - Europa 6.066
AS - Asia 1.507
SA - Sud America 46
AF - Africa 23
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 6
Totale 17.854
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.155
IT - Italia 1.748
GB - Regno Unito 1.744
DE - Germania 755
CN - Cina 591
SE - Svezia 559
SG - Singapore 424
FR - Francia 301
UA - Ucraina 233
HK - Hong Kong 193
PL - Polonia 155
FI - Finlandia 145
TR - Turchia 145
RU - Federazione Russa 118
BG - Bulgaria 90
IN - India 52
BE - Belgio 45
CA - Canada 38
BR - Brasile 36
IE - Irlanda 31
CH - Svizzera 30
ID - Indonesia 25
NL - Olanda 25
LT - Lituania 23
VN - Vietnam 18
JP - Giappone 14
CZ - Repubblica Ceca 13
ZA - Sudafrica 13
KR - Corea 12
ES - Italia 11
IR - Iran 11
PT - Portogallo 9
DK - Danimarca 8
MY - Malesia 8
EU - Europa 7
PK - Pakistan 7
CL - Cile 5
HU - Ungheria 5
AT - Austria 4
AU - Australia 3
GR - Grecia 3
MX - Messico 3
NZ - Nuova Zelanda 3
RO - Romania 3
TZ - Tanzania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AR - Argentina 2
BO - Bolivia 2
EG - Egitto 2
MA - Marocco 2
MD - Moldavia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BY - Bielorussia 1
CY - Cipro 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GL - Groenlandia 1
LV - Lettonia 1
NG - Nigeria 1
PH - Filippine 1
RS - Serbia 1
TN - Tunisia 1
TW - Taiwan 1
Totale 17.854
Salva come PNG Salva come JPEG
Città #
Southend 1.466
Fairfield 1.292
Santa Clara 1.056
Woodbridge 888
Ashburn 773
Chandler 753
Houston 588
Seattle 518
Ann Arbor 512
Jacksonville 465
Dearborn 458
Cambridge 454
Wilmington 440
Nyköping 363
Frankfurt am Main 361
Singapore 323
Modena 267
Hong Kong 191
Beijing 149
Kraków 145
New York 108
Princeton 98
Izmir 90
Sofia 90
San Diego 89
Eugene 87
Fremont 76
Milan 76
Helsinki 70
Redwood City 67
Shanghai 60
Rome 51
Boardman 49
Bologna 46
Bremen 46
Moscow 44
Brussels 40
Des Moines 35
London 35
Dublin 31
Grafing 30
Naples 30
Falls Church 28
Verona 28
Ottawa 26
Jakarta 24
Parma 23
Norwalk 22
Guangzhou 21
Hefei 20
Dong Ket 16
Paris 16
San Gimignano 14
Florence 13
Nanjing 13
Brno 12
Cape Town 12
Jinan 12
Kunming 12
Reggio Emilia 12
Saint Petersburg 12
Segrate 12
Milwaukee 11
Pavia 11
Perugia 11
Phoenix 11
Ferrara 10
Leawood 10
Napoli 10
Padova 10
Prato 10
Salerno 10
Trieste 10
Basel 9
Los Angeles 9
Torino 9
Amsterdam 8
Auburn Hills 8
Avellino 8
Kilburn 8
Munich 8
San Mateo 8
Sassuolo 8
Bari 7
Dallas 7
Palermo 7
Siena 7
Turin 7
Dongguan 6
Draveil 6
Misterbianco 6
Mountain View 6
Nanchang 6
Negrar 6
Toronto 6
Udine 6
Venice 6
Washington 6
Albinea 5
Aprilia 5
Totale 13.460
Salva come PNG Salva come JPEG
Nome #
STRUTTURA DEL CRISTALLO DEL COMPLESSO DI TIMIDILATO SINTETASI (TS) CON UN LIGANDO 665
Metodo per la funzionalizzazione sito specifica di molecole proteiche 346
Virtual Screening and X-ray Crystallography Identify Non-Substrate Analog Inhibitors of Flavin-Dependent Thymidylate Synthase 344
Internalization and stability of a thymidylate synthase peptide inhibitor in ovarian cancer cells 313
Virtual screening identification of nonfolate compounds, including a CNS drug, as antiparasitic agents inhibiting pteridine reductase 313
USO DI INIBITORI DELLA PTERIDINA REDUTTASI PER LA PREVENZIONE E/O IL TRATTAMENTO DI INFEZIONI PARASSITARIE 303
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 299
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections 290
Optimization of Peptides That Target Human Thymidylate Synthase to Inhibit Ovarian Cancer Cell Growth 274
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 274
Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance 271
2-Carboxyquinoxalines Kill Mycobacterium tuberculosis through Noncovalent Inhibition of DprE1 263
Profiling of Flavonol Derivatives for the Development of Antitrypanosomatidic Drugs 259
Current and Future Chemotherapy for Chagas Disease 253
Antibacterial agent discovery using thymidylate synthase biolibrary screening 251
2-[N-Alkyl(R-phenyl)-aminomethyl]-3-phenyl-7-trifluoromethylquinoxalines as anticancer agents inhibitors of folate enzymes 249
The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment 249
Conformational Propensity and Biological Studies of Proline Mutated LR Peptides Inhibiting Human Thymidylate Synthase and Ovarian Cancer Cell Growth 247
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 243
Constrained dansyl derivatives reveal bacterial specificity of highly conserved Thymidylate Synthases A 237
Crystal Structure of histidine-tagged human thymidylate synthase 234
2′-Deoxyuridine 5′-Monophosphate Substrate Displacement in Thymidylate Synthase through 6-Hydroxy-2H-naphtho[1,8-bc]furan-2-one Derivatives 233
NUOVE MOLECOLE, PER USO COME AGENTI ANTITUMORALI 230
Crystal Structure of human thymidylate synthase bound to a peptide inhibitor 228
X-ray crystal structures of Enterococcus faecalis thymidylate synthase with folate binding site inhibitors 228
Structure-Based Selectivity Optimization of Piperidine–Pteridine Derivatives as Potent Leishmania Pteridine Reductase Inhibitors 225
Methoxylated 2'-hydroxychalcones as antiparasitic hit compounds 225
Hotspots in an obligate homodimeric anticancer target. structural and functional effects of interfacial mutations in human thymidylate synthase 224
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To InhibitTrypanosoma bruceiPteridine Reductase in Support of Early-Stage Drug Discovery 222
“A step further in the discovery of phthalein derivatives as Thymidylate Synthase inhibitors” 222
Ligand-based discovery of N-(1,3-dioxo-1H,3H-benzo[de]isochromen-5-yl)-carboxamide and sulfonamide derivatives as thymidylate synthase A inhibitors 219
Modulation of the expression of folate cycle enzymes and polyamine metabolism by berberine in cisplatin-sensitive and -resistant human ovarian cancer cells 219
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 219
Thymidylate synthase structure, function and implication in drug discovery 218
Design and characterization of a mutation outside the active site of human thymidylate synthase that affects ligand binding. 217
Dimer-monomer equilibrium of human thymidylate synthase monitored by fluorescenceresonance energy transfer. 214
Maxwell A: F1000Prime Recommendation of Evaluation [Neres J et al., ACS Chem Biol 2014]. In F1000Prime, 09 Jan 2015; DOI: 10.3410/f.725248139.793502885. F1000Prime.com/725248139#eval793502885 214
SAR Studies and Biological Characterization of a Chromen-4-one Derivative as an Anti-Trypanosoma brucei Agent 212
Allosteric Inhibition of human Thymidylate Synthase. 203
Homodimeric Enzymes as Drug Targets 201
Tethering low affinity ligands to the dimeric interface of human thymidylate synthase. 201
Biochemical effects of riluzole on Leishmania parasites 200
Zing meeting on Medicinal Chemistry 2012-Lanzarote-invitated lecture 199
Update on antifolate drugs targets 198
A proteomic approach to investigate the mechanism of action of anticancer peptides 196
ANTICANCER DRUGS 194
Protein-protein interaction inhibitors: case studies on Small Molecules and Natural Compounds. 193
Inhibitor of Ovarian Cancer Cells growth by Virtual Screening: A New Thiazole Derivative Targeting Human Thymidylate Synthase 193
QUINOXALINE DERIVATIVES AS ANTITUBERCULOSIS AGENTS 192
Biochemistry: Anchors away 192
Improving specificity vs bacterial thymidylate synthases through N-dansyl modulation of didansyltyrosine 189
Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development 189
Development of flavonoids derivatives as leads against Leishmaniasis and Trypanosomiasis-invited lecture 186
Comparing Drug Images and Repurposing Drugs with BioGPS and FLAPdock: The Thymidylate Synthase Case 184
Alternative strategies in medicinal chemistry to face drug resistance in anticancer therapy. 180
Target-based approaches for the discovery of new antimycobacterial drugs 179
The structure of Cryptococcus neoformans thymidylate synthase suggests strategies for using target dynamics for species-specific inhibition 175
Synthesis of N-(5,7-diamino-3-phenyl-quinoxalin-2-yl)-3,4,5-substituted anilines and N-[4[(5,7-diamino-3-phenylquinoxalin-2-yl)amino]benzoyl]-l-glutamic acid diethyl ester: evaluation of in vitro anti-cancer and anti-folate activities 174
Targeting the trypanosomatidic enzymes pteridine reductase and dihydrofolate reductase. 174
Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth 173
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer-US8916679 “B2 - Granted patent as second publication”. 170
Fragment Based Discovery of Thymidylate Synthase Dimeric Interface Inhibitors Through Mass Spectrometry. Invited lecture to the Fragment Based Lead Discovery track. 167
Identification of the binding modes of N-phenylphthalimides inhibiting bacterial thymidylate synthase through X-ray crystallography screening. 166
COMPOSTI AD ATTIVITÀ ANTIPARASSITARIA 165
Intrinsic Fluorescence of the Active and the Inactive Functional Forms of Human Thymidylate Synthase 165
FRET-based assay for sensing a cancer key protein functional state and inhibition by oligopeptides: Sitespecific Protein Chemical Modifications 164
Unusual Targeting of the human Thymidylate synthase interface: a tethering approach with mass-spectrometric detection. 161
Peptides binding to the dimer interface of thymidylate synthase for the treatment of cancer 156
Hits and Lead Discovery in the Identification of New Drugs against the Trypanosomatidic Infections 154
Dal Ligand based design di inibitori della Timidilato Sintasi all'Analisi Comparativa dei Complessi Enzima-Inibitore 153
Anti-Parasitic drugsDiscovery of potent pteridine reductase inhibitors to guide antiparasite drug development. 149
Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase 146
Inhibitor Specificity via Protein Dynamics. Insights from the Design of Antibacterial Agents Targeted Against Thymidylate Synthase 145
The structure of Enterococcus faecalis thymidylate synthase provides clues about folate bacterial metabolism 140
Interfering with Human Thymidylate Synthase Dimerization against ovarian human carcinoma 140
Compounds having antiparasitic activity 138
Scaffolds and Biological Targets Avenue to Fight Against Drug Resistance in Leishmaniasis 138
Congress on - Medicinal Chemistry in parasitology: new avenues in drug discovery-organised in Modena in 2007. 135
Interfering with Human Thymidylate Synthase Dimerization anti peptide design in the search of anticancer agents against ovarian human carcinoma 134
Novel 3-benzoyl-2-piperazinylquinoxaline derivatives as potential antitumor agents 132
Ovarian Cancer Drug Resistance 132
Rapid-Throughput Technologies Applied to the Discovery of New Hits against Thymidylate synthase Enzymes 119
International Congress.Drug resistance in ovarian cancer:bomarkers andtreatments. 118
From ligand-based design to Hit validation of new thymidylate synthase inhibitors 105
Medicinal chemistry in parasitology 101
Sequence-based Identification of Specific Target Domains in the Thymidylate Synthase Enzyme Family. 98
Destabilizers of the thymidylate synthase homodimer accelerate its proteasomal degradation and inhibit cancer growth 96
Laboratory of reference for trypanosomatidic infections -In-Vitro-and-In-Vivo-Screenings-of-New-Antiparasitic-Compounds-State-of-the-art-and-New-Developments-COST B22 90
European COST B22 Lab for antiparasitic drug screening (http://www.icp.ucl.ac.be/cost/costB22/ screening_survey.pdf )-2008-2012. 85
The discovery of aryl-2-nitroethyl triamino pyrimidines as anti-Trypanosoma brucei agents 38
Intersite Communication in Dimeric Enzymes Highlighted by Structural and Thermodynamic Analysis of Didansyltyrosine Binding to Thymidylate Synthases 30
Totale 18.141
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.790 0 0 0 0 0 0 577 362 330 131 208 182
2020/20213.068 290 135 212 312 323 196 237 314 156 530 240 123
2021/20222.086 92 189 184 103 81 213 98 140 227 134 404 221
2022/20232.254 243 282 162 226 220 309 52 212 236 50 134 128
2023/20241.800 54 92 114 128 608 184 95 153 69 38 109 156
2024/20252.087 191 60 134 274 817 538 73 0 0 0 0 0
Totale 18.141